← back to search

Lothar H. Wieler

Hasso Plattner Institute · DE
Area of research
Endocrinology · Molecular Medicine
Research interest
Research interests include Escherichia coli research studies, Antibiotic Resistance in Bacteria, COVID-19 Digital Contact Tracing, and COVID-19 and Mental Health.
h-index
77
citations
23,892
works
502
NIH funding
primary concept
Biology
email

Recent publications

The AIR·MS data platform for artificial intelligence in healthcare.
2025cited by 1position: contributordoi
Leading and partnering in a crisis
Infectious Disease Emergencies: Preparedness and Response 2025cited by 0position: contributordoi
On the ecology of <i>Acinetobacter baumannii</i> – jet stream rider and opportunist by nature
2024cited by 8position: contributordoi
Quality of life and mental health in children and adolescents during the first year of the COVID-19 pandemic: results of a two-wave nationwide population-based study.
2023cited by 154position: contributordoi
Genome-wide association reveals host-specific genomic traits in Escherichia coli.
2023cited by 31position: contributordoi
Secondary data for global health digitalisation.
2023cited by 31position: contributordoi
Establishing Infodemic Management in Germany: A Framework for Social Listening and Integrated Analysis to Report Infodemic Insights at the National Public Health Institute.
2023cited by 14position: contributordoi
Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany-Results from the SeBluCo Study 2020-2022.
2023cited by 14position: contributordoi
An appeal for strengthening genomic pathogen surveillance to improve pandemic preparedness and infection prevention: the German perspective.
2023cited by 12position: contributordoi
Estimating the share of SARS-CoV-2-immunologically naïve individuals in Germany up to June 2022
Epidemiology and Infection 2023cited by 8position: middledoi
Moving cholera vaccines ahead of the epidemic curve
The Lancet 2023cited by 7position: middledoi
Estimating the share of SARS-CoV-2-immunologically naïve individuals in Germany up to June 2022.
2023cited by 6position: contributordoi
SARS-CoV-2 infections in migrant populations in Germany: results from the COVID-19 snapshot monitoring survey.
2023cited by 5position: contributordoi
[Establishment of genomic pathogen surveillance to strengthen pandemic preparedness and infection prevention in Germany].
2023cited by 5position: contributordoi
Migration and health: moving towards a diversity-oriented public health monitoring at the Robert Koch Institute.
2023cited by 1position: contributordoi
[Attitudes Toward Influenza Vaccination in Fall/Winter 2021: Results of the COSMO Study].
2023cited by 1position: contributordoi
Three Years into the Pandemic: Results of the Longitudinal German COPSY Study on Youth Mental Health and Health-Related Quality of Life
2023cited by 0position: contributordoi
[Application areas of artificial intelligence in the context of One Health with a focus on antimicrobial resistance].
2023cited by 0position: contributordoi
Child and Adolescent Mental Health During the COVID-19 Pandemic: Results of the Three-Wave Longitudinal COPSY Study.
2022cited by 146position: contributordoi
Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany.
2022cited by 110position: contributordoi
Nationally representative results on SARS-CoV-2 seroprevalence and testing in Germany at the end of 2020
Scientific Reports 2022cited by 32position: middledoi
Origin and Global Expansion of <i>Mycobacterium tuberculosis</i> Complex Lineage 3.
2022cited by 27position: contributordoi
A virulence factor as a therapeutic: the probiotic <i>Enterococcus faecium</i> SF68 arginine deiminase inhibits innate immune signaling pathways.
2022cited by 24position: contributordoi
Transmission of SARS-CoV-2 among children and staff in German daycare centres.
2022cited by 23position: contributordoi
Nationally representative results on SARS-CoV-2 seroprevalence and testing in Germany at the end of 2020.
2022cited by 19position: contributordoi
ICD-10 based syndromic surveillance enables robust estimation of burden of severe COVID-19 requiring hospitalization and intensive care treatment
2022cited by 4position: contributordoi
How to survive pig farming: Mechanism of SCC<i>mec</i> element deletion and metabolic stress adaptation in livestock-associated MRSA.
2022cited by 3position: contributordoi
Child and Adolescent Mental Health During the COVID-19 Pandemic: Results of the Three-Wave Longitudinal COPSY Study
2022cited by 2position: contributordoi
Estimating the distribution of COVID-19-susceptible, -recovered, and -vaccinated individuals in Germany up to April 2022
2022cited by 2position: contributordoi
Establishing Infodemic Management in Germany: A Framework for Social Listening and Integrated Analysis to Report Infodemic Insights at the National Public Health Institute (Preprint)
2022cited by 1position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Torsten Semmler · Robert Koch Institute13 papers (2014–2024) · 9 papers (2020–2025) · 7 papers (2019–2024)Andreas Nitsche · Zuse Institute Berlin5 papers (2020–2023)Mathias W. Pletz · Jena University Hospital4 papers (2020–2023)Hannelore Neuhauser · Robert Koch Institute4 papers (2021–2023)Stefan Niemann · University Hospital of Bern4 papers (2018–2022)Kumnuan Ungchusak · Ministry of Public Health3 papers (2020–2023)Gordon Dougan · University of Cambridge3 papers (2014–2019)Chikwe Ihekweazu · World of Medicine (Germany)3 papers (2020–2021)Ziad A. Memish · King Abdullah International Medical Research Center3 papers (2020–2023)Katharina Kranzer · Hospital for Tropical Diseases3 papers (2018–2020)Sandra Ciesek · Aschaffenburg University of Applied Sciences3 papers (2023–2023)Matthias Merker · University Hospital Frankfurt3 papers (2020–2022)Myoung‐don Oh · Chungnam National University2 papers (2020–2020)Elvira Richter · London School of Hygiene & Tropical Medicine2 papers (2018–2020)Delia Enría · Administración Nacional de Laboratorios e Institutos de Salud2 papers (2020–2020)Doris Hillemann · London School of Hygiene & Tropical Medicine2 papers (2018–2020)Dirk Brockmann · Robert Koch Institute2 papers (2020–2023)Amadou Alpha Sall · National Institute of Biomedical Research2 papers (2020–2020)